| Issue Date | Title | Author(s) |
| 2022 | Arrhythmia/Electrophysiology/Pacemaker/CRT-ICD | Boyuk, Ferit; Caliskan, Serhat; Kocabas, Umut; Cakmak, Ender Ozgun; Ozpelit, Ebru; Kasap, Mithat; Türk, Uğur Önsel |
| 2022 | Characteristics of Patients With Atrial Fibrillation on Edoxaban Treatment in Turkey: Baseline Data From Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (etaf-Tr) Study | Turk, Ugur Onsel ; Uguz, Berat; Inci, Sinan; Dost, Sahin; Tuluce, Kamil; Totan, Sahin; Erturk, Emre |
| 2022 | Characteristics of Patients With Atrial Fibrillation on Edoxaban Treatment in Turkey: Does Health Provider Type Matter? a Report From Etaf-Tr Study | Kocabas, Umut; Demirci, Gokhan; Yagmur, Burcu; Saricam, Ersin; Mammadli, Anar; Kasap, Mithat; Turk, Ugur Onsel |
| 2022 | Demographic, Clinical, and Disease Characteristics of Patients With Atrial Fibrillation on Edoxaban Therapy According To the Bleeding Risk: a Report From Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real | Avci, Eyup; Akgun, Didar Elif; Arslan, Ugur; Inci, Sinan; Yildirim, Ozge Turgay; Yenercag, Mustafa; Kasap, Mithat |
| 2022 | Demographic, Clinical, and Disease Characteristics of Patients With Atrial Fibrillation on Edoxaban Therapy According To the Stroke Risk: a Report From Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life Data | Akgun, Didar Elif; Avci, Eyup; Yavuz, Veysel; Isik, Turgay; Topuz, Sahin; Uludag, Demet Menekse Gerede; Totan, Sahin |
| 2022 | Demographic, Clinical, and Disease Characteristics of Patients With Atrial Fibrillation on Edoxaban Therapy: What Are the Impacts of Heart Failure? a Subgroup Analysis From Etaf-Tr Study | Bakhshaliyev, Nijad; Coner, Ali; Altin, Cihan ; Balli, Mehmet; Tasbulak, Omer; Totan, Sahin; Turk, Ugur Onsel |
| 2022 | How Did the Population Characteristics of Engage-Af Trial Transcribed Real Life Conditions in Turkey: an External Validation Test With Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (etna) | Baris, Veysel Ozgur; Erturk, Emre; Cetin, Nurullah; Bakir, Eren Ozan; Elcik, Deniz; Totan, Sahin; Turk, Ugur Onsel |
| 2022 | Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: the Anatolia-Af Study [pp. 59-61] | Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan |
| 2022 | Real-World Evaluation of Anticoagulant Treatment Patterns in Patients With Atrial Fibrillation: Data From Multicenter Rota Study [2022] | Kocabas, Umut; Ergin, Isil; Yavuz, Veysel; Murat, Selda; Ozdemir, Ibrahim; Genc, Omer; Altin, Cihan |
| 2022 | Stroke and Bleeding Risks According To Age Caterogories in Patients on Edoxaban | Basaran, Ozcan; Celik, Oguzhan; Kilic, Salih; Erdogan, Mehmet; Celik, Atac; Turan, Turhan; Kasap, Mithat |
| 2017 | Urban and Rural Differences in Hypertension Risk Factors in Turkey | Dastan, Ilker; Erem, Ayşegül ; Cetinkaya, Volkan |
